Prevention and Treatment of Pyrrolitinib-associated Diarrhea
Clinical trial NCT04736186 · UNKNOWN
Trial details
- NCT number
- NCT04736186
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-16
- Primary completion
- 2022-10-31
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.